Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (WHO, 2021).
Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259–264 (2021).
Taquet, M. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18, e1003773 (2021).
Group, P.-C. C. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 10, 761–775 (2022).
Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398, 747–758 (2021).
Augustin, M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Eur. 6, 100122 (2021).
Garcia-Abellan, J. et al. Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J. Clin. Immunol. 41, 1490–1501 (2021).
Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med. 27, 626–631 (2021).
Tleyjeh, I. M. et al. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: a cohort study with 4 months median follow-up. J. Infect. Public Health 15, 21–28 (2022).
Lui, D. T. W. et al. Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr. Pract. 27, 894–902 (2021).
Munipalli, B. et al. Risk factors for post-acute sequelae of COVID-19: survey results from a tertiary care hospital. J. Investig. Med. 71, 896–906 (2023).
Vasilevskaya, A. et al. Sex and age affect acute and persisting COVID-19 illness. Sci. Rep. 13, 6029 (2023).
Grossa, S. et al. Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study. Swiss Med. Wkly https://doi.org/10.4414/SMW.w30091 (2021).
Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 881–895 (2022).
Peluso, M. J. et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Invest. https://doi.org/10.1172/JCI163669 (2023).
Ryan, F. J. et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 20, 26 (2022).
Shuwa, H. A. et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med 2, 720–735 (2021).
Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210–216 (2022).
Cheong, J. G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell 186, 3882–3902 (2023).
Bergamaschi, L. et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 54, 1257–1275 (2021).
Bellmann-Weiler, R. et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J. Clin. Med. https://doi.org/10.3390/jcm9082429 (2020).
Bergamaschi, G. et al. Anemia in patients with COVID-19: pathogenesis and clinical significance. Clin. Exp. Med. 21, 239–246 (2021).
Hippchen, T., Altamura, S., Muckenthaler, M. U. & Merle, U. Hypoferremia is associated with increased hospitalization and oxygen demand in COVID-19 patients. Hemasphere 4, e492 (2020).
Shah, A. et al. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit. Care 24, 320 (2020).
Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271–1276 (2004).
Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093 (2004).
Weiss, G., Ganz, T. & Goodnough, L. T. Anemia of inflammation. Blood 133, 40–50 (2019).
Ganz, T. Anemia of inflammation. N. Engl. J. Med. 381, 1148–1157 (2019).
Morceau, F., Dicato, M. & Diederich, M. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators Inflamm. 2009, 405016 (2009).
Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).
Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165–176 (2016).
Hin, N., Newman, M., Pederson, S. & Lardelli, M. Iron responsive element-mediated responses to iron dyshomeostasis in Alzheimer’s disease. J. Alzheimer’s Dis. 84, 1597–1630 (2021).
Hanspers, K., Willighagen, E., Slenter, D., Hu, F. & Lupascu, D.-A. Ferroptosis (WP4313) https://www.wikipathways.org/instance/WP4313 (WikiPathways, 2021).
Zhou, Z. D. & Tan, E. K. Iron regulatory protein (IRP)–iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol. Neurodegener. 12, 75 (2017).
Muckenthaler, M. U., Galy, B. & Hentze, M. W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197–213 (2008).
Potts, M. et al. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity. Cell Rep. 42, 112613 (2023).
Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904–916 (2021).
Chicault, C. et al. Iron-related transcriptomic variations in CaCo-2 cells, an in vitro model of intestinal absorptive cells. Physiol. Genomics 26, 55–67 (2006).
Haschka, D. et al. Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes. JCI Insight https://doi.org/10.1172/jci.insight.98867 (2019).
Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419–1440 (2020).
Peluso, M. J. & Deeks, S. G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 43, 268–270 (2022).
Haase, V. H. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 27, 41–53 (2013).
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science https://doi.org/10.1126/science.abd4585 (2020).
Lanser, L. et al. Dynamics in anemia development and dysregulation of iron homeostasis in hospitalized patients with COVID-19. Metabolites https://doi.org/10.3390/metabo11100653 (2021).
Maccio, A. et al. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 100, 124–132 (2015).
Wilson, A., Yu, H. T., Goodnough, L. T. & Nissenson, A. R. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am. J. Med. 116, 50S–57S (2004).
Rodriguez, R. et al. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect. Immun. 82, 745–752 (2014).
Drakesmith, H., Nemeth, E. & Ganz, T. Ironing out ferroportin. Cell Metab. 22, 777–787 (2015).
Drakesmith, H. & Prentice, A. Viral infection and iron metabolism. Nat. Rev. Microbiol. 6, 541–552 (2008).
Erslev, A. Humoral regulation of red cell production. Blood 8, 349–357 (1953).
Dulmovits, B. M. et al. HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation. Blood 139, 3181–3193 (2022).
Khalil, S. et al. Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor. J. Exp. Med. 215, 661–679 (2018).
Libregts, S. F. et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 118, 2578–2588 (2011).
Bennett, L. F. et al. Inflammation induces stress erythropoiesis through heme-dependent activation of SPI-C. Sci. Signal. 12, eaap7336 (2019).
Jackson, A., Nanton, M. R., O’Donnell, H., Akue, A. D. & McSorley, S. J. Innate immune activation during Salmonella infection initiates extramedullary erythropoiesis and splenomegaly. J. Immunol. 185, 6198–6204 (2010).
Paulson, R. F., Hariharan, S. & Little, J. A. Stress erythropoiesis: definitions and models for its study. Exp. Hematol. 89, 43–54 (2020).
Yarosz, E. L. et al. Cutting Edge: Activation-induced iron flux controls CD4 T cell proliferation by promoting proper IL-2R signaling and mitochondrial function. J. Immunol. 204, 1708–1713 (2020).
Frost, J. N. et al. Plasma iron controls neutrophil production andfunction. Sci. Adv. 8, eabq5384 (2022).
Frost, J. N. et al. Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection. Med 2, 164–179 (2021).
Slusarczyk, P. et al. Impaired iron recycling from erythrocytes is an early hallmark of aging. eLife 12 https://doi.org/10.7554/eLife.79196 (2023).
Dorward, D. A. et al. Tissue-specific immunopathology in fatal COVID-19. Am. J. Respir. Crit. Care Med. 203, 192–201 (2021).
Baier, M. J. et al. Cardiac iron overload promotes cardiac injury in patients with severe COVID-19. Infection 50, 547–552 (2021).
Jacobs, W. et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature. ESC Heart Fail. 7, 3772–3781 (2020).
Del Nonno, F. et al. Hepatic failure in COVID-19: is iron overload the dangerous trigger? Cells https://doi.org/10.3390/cells10051103 (2021).
Littwitz-Salomon, E. et al. Metabolic requirements of NK cells during the acute response against retroviral infection. Nat. Commun. 12, 5376 (2021).
Kotagiri, P. et al. The impact of hypoxia on B cells in COVID-19. EBioMedicine 77, 103878 (2022).
Louati, K. & Berenbaum, F. Fatigue in chronic inflammation—a link to pain pathways. Arthritis Res. Ther. 17, 254 (2015).
Gregg, L. P., Bossola, M., Ostrosky-Frid, M. & Hedayati, S. S. Fatigue in CKD: epidemiology, pathophysiology, and treatment. Clin. J. Am. Soc. Nephrol. 16, 1445–1455 (2021).
Macdonald, J. H., Fearn, L., Jibani, M. & Marcora, S. M. Exertional fatigue in patients with CKD. Am. J. Kidney Dis. 60, 930–939 (2012).
Rineau, E. et al. Iron deficiency without anemia decreases physical endurance and mitochondrial complex I activity of oxidative skeletal muscle in the mouse. Nutrients https://doi.org/10.3390/nu13041056 (2021).
Jauregui-Lobera, I. Iron deficiency and cognitive functions. Neuropsychiatr. Dis. Treat. 10, 2087–2095 (2014).
Benton, D. Micronutrient status, cognition and behavioral problems in childhood. Eur. J. Nutr. 47, 38–50 (2008).
Lee, H. S., Chao, H. H., Huang, W. T., Chen, S. C. & Yang, H. Y. Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: a nationwide database analysis. BMC Psychiatry 20, 216 (2020).
Sonnweber, T. et al. The impact of iron dyshomeostasis and anaemia on long-term pulmonary recovery and persisting symptom burden after COVID-19: a prospective observational cohort study. Metabolites https://doi.org/10.3390/metabo12060546 (2022).
El-Battrawy, I. et al. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: data from an international registry. J. Cell. Mol. Med. 26, 2520–2528 (2022).
Kalra, P. R. et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400, 2199–2209 (2022).
Kalra, P. R. et al. Novel predictors of new-onset atrial fibrillation following the event of ST-elevation myocardial infarction. Eur. J. Heart Fail https://doi.org/10.1002/ejhf.2927 (2023).
Wang, C. Y. & Babitt, J. L. Hepcidin regulation in the anemia of inflammation. Curr. Opin. Hematol. 23, 189–197 (2016).
van Eijk, L. T. et al. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood 124, 2643–2646 (2014).
Hashimoto, M. et al. Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS ONE 9, e98202 (2014).
Song, S. N. et al. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116, 3627–3634 (2010).
Abani, O. et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637–1645 (2021).
Wang, M. P., Joshua, B., Jin, N. Y., Du, S. W. & Li, C. Ferroptosis in viral infection: the unexplored possibility. Acta Pharmacol. Sin. 43, 1905–1915 (2022).
The PREVAIL III Study Group et al. A longitudinal study of Ebola sequelae in Liberia. N. Engl. J. Med. 380, 924–934 (2019).
Bond, N. G. et al. Post-Ebola syndrome presents with multiple overlapping symptom clusters: evidence from an ongoing cohort study in Eastern Sierra Leone. Clin. Infect. Dis. 73, 1046–1054 (2021).
Chen, J. et al. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci. Rep. 7, 17275 (2017).
Tansey, C. M. et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 167, 1312–1320 (2007).
Turner-Stokes, L. et al. The post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part I: development and preliminary clinimetric evaluation. J. Intensive Care Soc. 23, 253–263 (2022).
R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2021).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
Wu, D. & Smyth, G. K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40, e133 (2012).
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
Mulè, M. P., Martins, A. J. & Tsang, J. S. Normalizing and denoising protein expression data from droplet-based single cell profiling. Nat. Commun. 13, 2099 (2022).
Rohart, F., Gautier, B., Singh, A. & Le Cao, K. A. mixOmics: an R package for ‘omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).
